| Literature DB >> 33388695 |
Qin Shu1, Hanghang Lou1, Tianyu Wei1, Xinglin Zhang1, Qihe Chen2.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is drug-resistant and biofilm-forming pathogenic bacteria with severe morbidity and mortality, and has been continuously detected in food products in recent years. Mannosylerythritol lipids (MELs) are novel biosurfactants and perform antibacterial property against gram-positive bacteria. Ultrasound has been applied into food sterilization as non-thermal techniques and has advantage of maintaining food nutrition and flavor over heat pasteurization. In this work, the synergistic treatment of ultrasound and MEL-A was used to combat planktonic cells and biofilm of MRSA. As a result, the combined treatment has exhibited remarkable antibacterial effect proved by enumeration of viable microbes. Furthermore, flow cytometry, scanning electron microscopy and transmission electron microscopy revealed ultrasound has enhanced the inhibitory effect of MEL-A through exacerbating cell membrane damage. On the other hand, the collaborating working modes to eradicate MRSA biofilm were disturbing cell adhesion to surface by MEL-A and destructing mature biofilm mechanically by ultrasound, reaching to over 90% of clearance rate. The findings of this study illustrated the synergistic antimicrobial mechanism of ultrasound and MEL-A treatments, and offered theoretical basis for their potential applications in food preservation.Entities:
Keywords: Antibacterial; Antibiofilm; Mannosylerythritol lipid-A (MEL-A); Methicillin-resistant Staphylococcus aureus (MRSA); Ultrasound
Mesh:
Substances:
Year: 2020 PMID: 33388695 PMCID: PMC7803934 DOI: 10.1016/j.ultsonch.2020.105452
Source DB: PubMed Journal: Ultrason Sonochem ISSN: 1350-4177 Impact factor: 7.491
Fig. 1Time killing investigation of MEL-A against MRSA cells. (A): Killing kinetics of MEL-A. (B) Spot plates of MRSA with MEL-A treatment at different times.
Quantity of dead MRSA cells after US (1.85, 2.77,3.69 W/cm2), MEL-A (256 μg/mL) and MEL-A + US treatment for 5/10/15 min, respectively.
| Time (min) | US (reduction log CFU/mL) | MEL-A (reduction log CFU/mL) | MEL-A+US (reduction log CFU/mL) | ||||
|---|---|---|---|---|---|---|---|
| 1.85 W/cm2 | 2.77 W/cm2 | 3.69 W/cm2 | 1.85 W/cm2 | 2.77 W/cm2 | 3.69 W/cm2 | ||
| 5 | 0.03±0.10a | 0.13±0.10abc | 0.17±0.06abcd | 0.18±0.11abcd | 0.09±0.05ab | 0.34±0.17de | 1.16±0.04f |
| 10 | 0.12±0.09abc | 0.27±0.07bcde | 0.24±0.07bcde | 0.15±0.07abcd | 0.20±0.06abcd | 0.39±0.16e | 1.26±0.13 f |
| 15 | 0.15±0.09abcd | 0.29±0.04cde | 0.28±0.13bcde | 0.25±0.12bcde | 0.30±0.12cde | 0.41±0.05e | 1.32±0.10 f |
Note: Individual data were expressed as mean ± standard error (n=3). Different letters indicate a significant difference cross the table (P < 0.05).
Fig. 2Leakage of intracellular constituents. (A) Leakage of intracellular proteins. (B) Leakage of intracellular nucleic acids. C: control; US: ultrasound; M: MEL-A; M-US: MEL-A and ultrasound.
Fig. 3Fluorescent cell micrographs of MRSA under different treatments. (A) control; (B) ultrasound; (C) MEL-A; (D) MEL-A and ultrasound.
Fig. 4SEM images of MRSA under different treatments. (A) control; (B) ultrasound; (C) MEL-A; (D) MEL-A and ultrasound.
Fig. 5TEM images of MRSA under different treatments. (A) control; (B) ultrasound; (C) MEL-A; (D) MEL-A and ultrasound.
Fig. 6Eradication effect of MEL-A on MRSA biofilm.
Fig. 7Eradication effect of MEL-A and ultrasound on MRSA biofilm.
Fig. 8Confocal laser scanning microscopic images of MRSA biofilm. C: control; US: ultrasound; M: MEL-A; M-US: MEL-A and ultrasound.
Fig. 9Diagram of the postulated synergistic antibacterial and antibiofilm mechanism of ultrasound and MEL-A against MRSA